Copyright
©The Author(s) 2021.
World J Diabetes. Jun 15, 2021; 12(6): 767-779
Published online Jun 15, 2021. doi: 10.4239/wjd.v12.i6.767
Published online Jun 15, 2021. doi: 10.4239/wjd.v12.i6.767
Figure 2 The Ca2+/3'-5'-cyclic adenosine monophosphate signaling dysregulations and their consequences.
Up arrow: Increasing; Down arrow: Decreasing. [Ca2+]c: Intracellular concentration of Ca2+; [cAMP]c: Intracellular concentration of 3'-5'-cyclic adenosine monophosphate.
- Citation: Bergantin LB. Diabetes and inflammatory diseases: An overview from the perspective of Ca2+/3'-5'-cyclic adenosine monophosphate signaling. World J Diabetes 2021; 12(6): 767-779
- URL: https://www.wjgnet.com/1948-9358/full/v12/i6/767.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i6.767